Gary Myerson
Rheumatology · Atlanta, GANPI 1346282399
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $822,883 of the $1,017,480 with a category attached, or 80.9%. 32 manufacturers reported payments, led by Amgen at 50.5% of the total. Among rheumatology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,899 payments — averaging $535.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$514K
- AstraZeneca$256K
- Pfizer$72K
- Radius Health, Inc.$66K
- Lilly USA, LLC$25K
- Aurinia Pharma U.S., Inc.$23K
- plus $61K from 26 others
Across 71 payments — averaging $4321.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$117K
- Regeneron$106K
- Amgen$34K
- Eli Lilly$24K
- Novartis$14K
- Mallinckrodt Enterprises LLC$8K
- plus $4K from 1 others
What the payments were for
- Consulting fees$30,9933%
- Speaking & faculty fees$822,88381%
- Travel & lodging$128,49513%
- Food & beverage$35,0013%
- Education$1080%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 866 | $513,871 |
| AstraZeneca(2 entities) | 350 | $256,099 |
| Pfizer | 128 | $72,242 |
| Radius Health, Inc. | 92 | $66,109 |
| Lilly USA, LLC | 61 | $24,788 |
| Aurinia Pharma U.S., Inc. | 42 | $23,188 |
| Novartis | 40 | $16,482 |
| GSK | 55 | $15,527 |
| Bristol Myers Squibb | 37 | $14,479 |
| AbbVie | 91 | $6,001 |
| Gilead | 14 | $5,248 |
| UCB, Inc. | 25 | $1,470 |
| E.r. Squibb & Sons, L.L.C. | 29 | $471 |
| Eli Lilly | 1 | $288 |
| Johnson & Johnson | 25 | $254 |
| Medexus Pharma, Inc. | 7 | $177 |
| Sanofi | 2 | $123 |
| Mallinckrodt Enterprises LLC | 5 | $109 |
| Boehringer Ingelheim | 5 | $87 |
| Regeneron Healthcare Solutions, Inc. | 1 | $65 |
| Sanofi-aventis U.S. LLC | 3 | $59 |
| Pacira Therapeutics, Inc. | 4 | $58 |
| Merck | 4 | $53 |
| Actelion Pharmaceuticals US, Inc. | 2 | $46 |
| ANI Pharmaceuticals, Inc. | 2 | $45 |
| Genentech USA, Inc. | 2 | $33 |
| Sobi, Inc | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Organon | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,017,480 in reported general payments places this provider in the 95th percentile of 177 rheumatology providers in Georgia.
Other rheumatology in Atlanta
- William WilsonAtlanta$344K
- Paul SutejAtlanta$140K
- Sung LimAtlanta$125K
- Arezou KhosroshahiAtlanta$66K
- Kimberley WilsonAtlanta$41K
- John GoldmanAtlanta$33K
- Wambui MachuaAtlanta$31K
- Paula TanasaAtlanta$31K
- Rattandeep SinghAtlanta$20K
- Elizabeth ButlerAtlanta$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.